Congress Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Congress Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$192K	–	240
2016 Q1	$192K	Hold	30,000	–	–	﹤0.01%	223
2015 Q4	$188K	Hold	30,000	–	–	﹤0.01%	226
2015 Q3	$175K	Hold	30,000	–	–	﹤0.01%	211
2015 Q2	$248K	Hold	30,000	–	–	0.01%	216
2015 Q1	$247K	Hold	30,000	–	–	0.01%	212
2014 Q4	$206K	Hold	30,000	–	–	0.01%	229
2014 Q3	$162K	Hold	30,000	–	–	﹤0.01%	233
2014 Q2	$191K	Hold	30,000	–	–	﹤0.01%	236
2014 Q1	$242K	Hold	30,000	–	–	0.01%	227
2013 Q4	$205K	Hold	30,000	–	–	0.01%	222
2013 Q3	$552K	Hold	30,000	–	–	0.02%	190
2013 Q2	$525K	Buy	+30,000	New	+$532K	0.02%	189

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Congress Asset Management's ARIA Position: Q2 2016 in Review

Congress Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 30,000 shares — an estimated $192K sold.

Congress Asset Management first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $552K in Q3 2013. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

Congress Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Congress Asset Management sold 30,000 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $192K.
Congress Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
Congress Asset Management's Ariad Pharmaceuticals Inc position peaked at $552K in Q3 2013.
182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on Congress Asset Management's 13F filing for Q2 2016, filed 4 Aug 2016.